DEVELOPING A PERSONALIZED MEDICINE APPROACH FOR TREATING TYPE 2 DIABETES

Abstract

Every year, type 2 diabetes (T2D), a global public health concern, is becoming more prevalent in Asia, particularly Taiwan.    Both genetic and environmental variables affect the likelihood of type 2 diabetes and its effects.    Polymorphisms at particular loci may be useful in identifying those who are most at risk and who may react to oral antidiabetic medications, according to genetic association studies.    Using our research sample as examples, this review examines the relationship between genetic profiling and type 2 diabetes and its consequences.  The research will also look at the pharmacogenetics and pharmacogenomics of oral diabetes drugs.  Personalized medicine, which involves discovering unique patient information and then suggesting a treatment suited to that patient's needs, is a new concept in the treatment of disease.